Business Description
Immatics NV
NAICS : 541713
SIC : 2833
ISIN : NL0015285941
Share Class Description:
FRA:4A3: Ordinary SharesDescription
Immatics NV is a biotechnology company that is engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 30.61 | |||||
| Equity-to-Asset | 0.66 | |||||
| Debt-to-Equity | 0.04 | |||||
| Debt-to-EBITDA | -0.45 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 1.88 | |||||
| Beneish M-Score | 0.48 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -2.6 | |||||
| 3-Year EBITDA Growth Rate | 38.8 | |||||
| 3-Year EPS without NRI Growth Rate | 11.7 | |||||
| 3-Year FCF Growth Rate | 57.5 | |||||
| 3-Year Book Growth Rate | 19.7 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 60.09 | |||||
| 9-Day RSI | 48.58 | |||||
| 14-Day RSI | 44.33 | |||||
| 6-1 Month Momentum % | -20.02 | |||||
| 12-1 Month Momentum % | 11.04 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.98 | |||||
| Quick Ratio | 3.98 | |||||
| Cash Ratio | 3.81 | |||||
| Days Sales Outstanding | 7.64 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -10.4 | |||||
| Shareholder Yield % | -19.8 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -57.59 | |||||
| Net Margin % | -48 | |||||
| FCF Margin % | -38.54 | |||||
| ROE % | -16.99 | |||||
| ROA % | -9.96 | |||||
| ROIC % | -45.1 | |||||
| ROC (Joel Greenblatt) % | -80.03 | |||||
| ROCE % | -11.23 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 6.48 | |||||
| PB Ratio | 1.92 | |||||
| Price-to-Tangible-Book | 2.03 | |||||
| EV-to-EBIT | -8.91 | |||||
| EV-to-EBITDA | -11.62 | |||||
| EV-to-Revenue | 3.61 | |||||
| EV-to-FCF | -9.54 | |||||
| Price-to-Net-Current-Asset-Value | 2.44 | |||||
| Price-to-Net-Cash | 2.63 | |||||
| Earnings Yield (Greenblatt) % | -11.22 | |||||
| FCF Yield % | -5.08 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Immatics NV Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 115.504 | ||
| EPS (TTM) (€) | -0.62 | ||
| Beta | 0.72 | ||
| Volatility % | 42.95 | ||
| 14-Day RSI | 44.33 | ||
| 14-Day ATR (€) | 0.320907 | ||
| 20-Day SMA (€) | 7.894 | ||
| 12-1 Month Momentum % | 11.04 | ||
| 52-Week Range (€) | 7.14 - 12.9 | ||
| Shares Outstanding (Mil) | 121.55 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Immatics NV Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Immatics NV Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Immatics NV Frequently Asked Questions
What is Immatics NV(FRA:4A3)'s stock price today?
The current price of FRA:4A3 is €7.72. The 52 week high of FRA:4A3 is €12.90 and 52 week low is €7.14.
When is next earnings date of Immatics NV(FRA:4A3)?
The next earnings date of Immatics NV(FRA:4A3) is 2025-03-21 Est..
Does Immatics NV(FRA:4A3) pay dividends? If so, how much?
Immatics NV(FRA:4A3) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers